The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
98290454 9829045 4 F 2012 20160831 20140118 20160906 EXP CA-ROCHE-1334322 ROCHE 48.99 YR F Y 71.70000 KG 20160906 MD CA CA

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
98290454 9829045 1 PS RITUXAN RITUXIMAB 1 Intravenous (not otherwise specified) RECEIVED RITUXIMAB INFUSION ?24/JUL/2009 (1000 DAY 1, 15 (1ST RPAP DOSE)?23/AUG/2013, 24/FEB/2014 Y N3722 103705 1000 MG SOLUTION FOR INFUSION
98290454 9829045 2 SS RITUXAN RITUXIMAB 1 Intravenous (not otherwise specified) DAY 1, 15?MOST RECENT DOSE 31/AUG/2016 Y N3722 103705 1000 MG SOLUTION FOR INFUSION
98290454 9829045 3 SS ACTEMRA TOCILIZUMAB 1 Intravenous (not otherwise specified) 125276 256 MG SOLUTION FOR INFUSION
98290454 9829045 4 C CELEBREX CELECOXIB 1 Oral 0 200 MG BID
98290454 9829045 5 C NEXIUM ESOMEPRAZOLE MAGNESIUM 1 Oral EVEREY DAY 0 40 MG
98290454 9829045 6 C TYLENOL EXTRA STRENGTH ACETAMINOPHEN 1 0
98290454 9829045 7 C DIPHENHYDRAMINE HCL DIPHENHYDRAMINE HYDROCHLORIDE 1 Oral 0 50 MG
98290454 9829045 8 C DIPHENHYDRAMINE HCL DIPHENHYDRAMINE HYDROCHLORIDE 1 Oral 0 50 MG
98290454 9829045 9 C ACETAMINOPHEN. ACETAMINOPHEN 1 Oral 0 1000 MG
98290454 9829045 10 C ACETAMINOPHEN. ACETAMINOPHEN 1 Oral 0 650 MG
98290454 9829045 11 C ACETAMINOPHEN. ACETAMINOPHEN 1 Oral 0 1000 MG
98290454 9829045 12 C METHOTREXATE. METHOTREXATE 1 Unknown 0
98290454 9829045 13 C METHYLPREDNISOLONE. METHYLPREDNISOLONE 1 Intravenous (not otherwise specified) 0 100 MG
98290454 9829045 14 C METHYLPREDNISOLONE. METHYLPREDNISOLONE 1 Intravenous (not otherwise specified) 0 100 MG

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
98290454 9829045 1 Rheumatoid arthritis
98290454 9829045 3 Rheumatoid arthritis
98290454 9829045 7 Premedication
98290454 9829045 9 Premedication

Outcome of event

Event ID CASEID OUTC COD
98290454 9829045 OT
98290454 9829045 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
98290454 9829045 Abdominal pain
98290454 9829045 Drug effect decreased
98290454 9829045 Feeling abnormal
98290454 9829045 Headache
98290454 9829045 Heart rate decreased
98290454 9829045 Hypotension
98290454 9829045 Immunodeficiency
98290454 9829045 Intervertebral disc protrusion
98290454 9829045 Menstrual disorder
98290454 9829045 Nausea
98290454 9829045 Oropharyngeal pain
98290454 9829045 Ovarian mass
98290454 9829045 Pelvic inflammatory disease
98290454 9829045 Salpingitis
98290454 9829045 Tubo-ovarian abscess
98290454 9829045 Vaginal infection

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
98290454 9829045 1 2006 20140825 0
98290454 9829045 2 20160817 0
98290454 9829045 3 20151008 20160510 0
98290454 9829045 7 20090724 0
98290454 9829045 8 20160817 0
98290454 9829045 9 20090724 0
98290454 9829045 10 20160817 20160817 0
98290454 9829045 11 20160831 0
98290454 9829045 12 1996 1998 0
98290454 9829045 13 20090724 0
98290454 9829045 14 20160817 0